Both in Pharmaceuticals
Seres Therapeutics vs TherapeuticsMD
Over the past year MCRB returned −89.6% and TXMD returned +48.8%; their daily moves had a correlation of -0.05.
MCRB −89.6% TXMD +48.8%Growth of $1, one year, split-adjusted
| Metric | MCRB | TXMD |
|---|---|---|
| Price | $1.75 | $1.80 |
| Market cap | $17.6M | $20.8M |
| Today | −10.26% | −1.64% |
| 1 month | −40.3% | −11.3% |
| 6 months | −77.0% | −13.0% |
| Year to date | −88.2% | +10.4% |
| 1 year | −89.6% | +48.8% |
| Revenue growth (YoY) | — | −8.7% |
| Gross margin | 100.0% | 100.0% |
| Net margin | 622.4% | 17.8% |
| P/E (TTM) | — | — |
| Price / sales | 9.3× | 6.4× |
| Net cash | $15.6M | $9.2M |
| Dividend yield | — | — |
| Volatility (60d) | 71.0% | 33.7% |
| Short % of float | 4.4% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).